This study tests a new drug called PRI-002 in 304 people with mild memory problems or early Alzheimer's. The drug aims to break apart harmful protein clumps in the brain that are linked to Alzheimer's. Researchers want to see if it is safe and can slow down memory and thinking de…
Phase: PHASE2 • Sponsor: PRInnovation GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC